When cancer is diagnosed, finding treatment options is the top priority
OncoTarget® Series is our comprehensive genomic profiling solution to identify targeted immunotherapies for advanced cancers– solid tumors or leukemias.
Learn about our newly launched, FDA cleared, 500-gene panel OncoTarget® 500
OncoTarget® Series Test Menu
OncoTarget® 500
FDA cleared gene panel testing
OncoTarget® Myeloid68
An NGS-Based Test For Myeloid Leukemia
OncoTarget® Liquid
Hematology Molecular Panel
Hematology FISH Panel
Immuno Profile Panel
Your confidence is found within OncoTarget’s
multi-technology platform
MSI and single mutations
Sample Collection
Sample Processing
Results
GoPath® Diagnostics Launches FDA-Cleared CGP Test under OncoTarget® 500
#ASCO22 week is here and we are excited to announce the release of our FDA-Cleared CGP Test under OncoTarget® 500.

Visit us in booth #28109 on June 4-6 between 9:00 AM–5:00 PM each day and learn how this CGP solution will help advance cancer treatments by identifying genomic targets for both targeted therapy and immunotherapy.
Learn more
Stay connected
Get in touch
About us
Individuals
Providers
Resources
Contact
Call us: (855) 467-2849
Email: contact@gopathlabs.com

Address: 1000 Corporate Grove Dr,
Buffalo Grove, IL, 60089

Business Hours
Monday – Friday: 8:00am-5:00pm
Saturday – Sunday – Closed
© GoPath Global, Inc. 2022 All rights reserved
Terms of use
Privacy Policy